Atlas Trials

Evaluation of Antiproliferative Effects of Arimidex in Ductal Lavage Fluid in Patients With Breast Cancer

Clinical trial NCT01207635 · COMPLETED

Trial details

NCT number
NCT01207635
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2002-11-01
Primary completion
2006-01-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.